Management of Severe Anti-Tumor Necrosis Factor (TNF) Induced Psoriasis in Patients with Inflammatory Bowel Disease

被引：1
|
作者：
Gold, Stephanie L. [1 ]
Cohen-Mekelburg, Shirley [1 ]
Schneider, Yecheskel [1 ]
Steinlauf, Adam [2 ]
机构：
[1] New York Presbyterian Weill Cornell Med Ctr, New York, NY USA
[2] Weill Cornell Med Coll, New York, NY USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2016年 / 111卷
关键词：
D O I：
10.14309/00000434-201610001-01732
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1732
引用
收藏
页码：S827 / S827
页数：1
相关论文
共 50 条
  • [41] Economic Outcomes of Inflammatory Bowel Disease Patients Switching to a Second Anti-Tumor Necrosis Factor or Vedolizumab
    Chiorean, Michael
    Afzali, Anita
    Cross, Raymond K.
    Macaulay, Dendy
    Griffith, Jenny
    Wang, Anthony
    Garcia-Horton, Viviana
    CROHNS & COLITIS 360, 2020, 2 (02)
  • [42] Factors Associated with the Immunogenicity of Anti-Tumor Necrosis Factor Agents in Pediatric Patients with Inflammatory Bowel Disease
    Kim, Ju Young
    Lee, Yoon
    Choe, Byung-Ho
    Kang, Ben
    GUT AND LIVER, 2021, 15 (04) : 588 - 598
  • [43] Aortic Stiffness in Patients With Inflammatory Bowel Disease Reduced After Anti-Tumor Necrosis Factor Therapy
    Zanoli, Luca
    Inserra, Gaetano
    Cappello, Maria
    Ozturk, Kadir
    Castellino, Pietro
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (08) : 981 - 982
  • [44] Liver Diseases Associated with Anti-Tumor Necrosis Factor-alpha (TNF-α) Use for Inflammatory Bowel Disease
    Coffin, Carla S.
    Fraser, Hughie F.
    Panaccione, Remo
    Ghosh, Subrata
    INFLAMMATORY BOWEL DISEASES, 2011, 17 (01) : 479 - 484
  • [45] Anxiety and Depression Leads to Anti-Tumor Necrosis Factor Discontinuation in Inflammatory Bowel Disease
    Dolovich, Casandra
    Bernstein, Charles N.
    Singh, Harminder
    Nugent, Zoann
    Tennakoon, Aruni
    Shafer, Leigh Ann
    Marrie, Ruth Ann
    Sareen, Jitender
    Targownik, Laura E.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (06) : 1200 - +
  • [46] Risk factors for tuberculosis in inflammatory bowel disease: anti-tumor necrosis factor and hospitalization
    Riestra, Sabin
    de Francisco, Ruth
    Arias-Guillen, Miguel
    Saro, Cristina
    Garcia-Alvarado, Maria
    Duque, Jose M.
    Jose Palacios, Juan
    Munoz, Fernando
    Blanco, Lorena
    Castano, Olegario
    Perez-Martinez, Isabel
    Martinez-Camblor, Pablo
    Perez-Hernandez, Dolores
    Suarez, Adolfo
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2016, 108 (09) : 541 - 549
  • [47] Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti-Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease
    Cottone, Mario
    Kohn, Anna
    Daperno, Marco
    Armuzzi, Alessandro
    Guidi, Luisa
    D'Inca, Renata
    Bossa, Fabrizio
    Angelucci, Erika
    Biancone, Livia
    Gionchetti, Paolo
    Ardizzone, Sandro
    Papi, Claudio
    Fries, Walter
    Danese, Silvio
    Riegler, Gabriele
    Cappello, Maria
    Castiglione, Fabiana
    Annese, Vito
    Orlando, Ambrogio
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (01) : 30 - 35
  • [48] Risk Factors and Outcomes in Inflammatory Bowel Disease Patients With Anti-Tumor Necrosis Factor Alpha-Induced Dermatologic Conditions
    Yoon, Bo Hyung
    Javia, Amy
    Berman, Ethan
    Kozuch, Patricia
    Shivashankar, Raina
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S412 - S412
  • [49] Management of Non-response and Loss of Response to Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease
    Marsal, Jan
    Barreiro-de Acosta, Manuel
    Blumenstein, Irina
    Cappello, Maria
    Bazin, Thomas
    Sebastian, Shaji
    FRONTIERS IN MEDICINE, 2022, 9
  • [50] Anti-tumor necrosis factor therapy for pediatric inflammatory bowel diseases
    Bujanover, Yoram
    Weiss, Batia
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2008, 10 (8-9): : 634 - 639
12345